ISR 2017 KNBSB Decision Disciplinary Committee 2017011 T

Related case:
ISR 2018 KNBSB Decision Appeal Committee 2017011 B
April 18, 2018

In September 2017 the Royal Dutch Baseball and Softball Federation (KNBSB) has reported an anti-doping rule violation against the Person after his sample tested positive for the prohibited substance Dehydrochlormethyltestosterone. After notification a provisional suspension was ordered.

The Person didn’t file a statement in his defence nor did he request a hearing. He only alleged that the supplement Xtreme Test 2.0 he used was the probable source of the positive analytical finding and requested the Dopingautoriteit to test this supplement. However the WADA accredited laboratory reported in October 2017 that analysis of this supplement didn’t reveal the presence of prohibited substances.

Without the Person’s response the ISR-KNBSB Disciplinary Committee concludes that the evidence establish that the Person committed the anti-doping rule violation and that there are no grounds for a reduced sanction.
Therefore the ISR-KNBSB Disciplinary Committee decides on 22 December 2018 to impose a 4 year period of ineligibility on the Person starting on the date of the provisional suspension, i.e. on 9 August 2017.

Fees and expenses for this committee shall be borne by the Person.

Original document

Parameters

Legal Source
National Decisions
Date
22 December 2017
Arbitrator
Assum, G.R.M. van
Maanicus, R.M.
Vilé, E.J.A.
Original Source
Doping Authority Netherlands
Country
Netherlands
Language
Dutch
ADRV
Adverse Analytical Finding / presence
Legal Terms
Waiver of "right to be heard"
Sport/IFs
Baseball-Softball (WBSC) - World Baseball-Softball Confederation
Other organisations
Dopingautoriteit - Anti-Doping Authority Netherlands (ADAN)
Instituut Sportrechtspraak (ISR) - Dutch Institute of Arbitration in Sports
KNBSB - Koninklijke Nederlandse Baseball en Softball Bond
Laboratories
Ghent, Belgium: DoCoLab Universiteit Gent-UGent
Doping classes
S1. Anabolic Agents
Substances
Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Various
Contamination
Supplements
Document type
Pdf file
Date generated
3 May 2018
Date of last modification
25 October 2018
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin